US Stock MarketDetailed Quotes

Heron Therapeutics (HRTX)

Watchlist
  • 1.1900
  • +0.1902+19.02%
Close Apr 24 16:00 ET
  • 1.1996
  • +0.0096+0.81%
Post 19:46 ET
224.36MMarket Cap-9.92P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Heron Therapeutics (HRTX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
7.36%154.9M
-0.47%40.59M
16.47%38.21M
3.26%37.2M
12.21%38.9M
13.57%144.29M
19.13%40.78M
4.38%32.81M
13.42%36.02M
17.07%34.67M
Operating revenue
7.36%154.9M
-0.47%40.59M
16.47%38.21M
3.26%37.2M
12.21%38.9M
13.57%144.29M
19.13%40.78M
4.38%32.81M
13.42%36.02M
17.07%34.67M
Cost of revenue
6.98%41.35M
8.71%11.12M
25.97%11.91M
-6.28%9.86M
0.15%8.46M
-40.64%38.65M
3.47%10.23M
-48.06%9.46M
-47.82%10.52M
-49.90%8.44M
Gross profit
7.50%113.56M
-3.55%29.47M
12.62%26.3M
7.20%27.34M
16.09%30.45M
70.55%105.64M
25.48%30.55M
76.56%23.35M
119.80%25.51M
105.52%26.23M
Operating expense
-0.91%116.1M
11.57%29.43M
9.28%30.39M
-9.30%28.98M
-12.03%27.29M
-32.10%117.17M
-23.69%26.38M
-27.11%27.81M
-40.84%31.95M
-32.30%31.02M
Selling and administrative expenses
3.17%103.67M
10.70%25.69M
15.32%26.92M
-5.35%26.05M
-5.31%25.01M
-24.69%100.48M
-13.32%23.2M
-19.14%23.35M
-32.55%27.52M
-28.58%26.42M
-Selling and marketing expense
4.20%49.06M
10.64%12.23M
17.95%12.94M
-14.98%11.58M
7.59%12.31M
-30.39%47.09M
-10.31%11.06M
-15.31%10.97M
-35.80%13.61M
-45.91%11.44M
-General and administrative expense
2.26%54.61M
10.76%13.45M
12.99%13.98M
4.07%14.47M
-15.17%12.7M
-18.82%53.4M
-15.88%12.15M
-22.25%12.37M
-29.03%13.91M
-5.43%14.97M
Research and development costs
-25.50%12.43M
17.87%3.75M
-22.28%3.47M
-33.80%2.93M
-50.54%2.28M
-57.37%16.68M
-59.27%3.18M
-51.91%4.47M
-66.45%4.43M
-47.85%4.61M
Operating profit
77.98%-2.54M
-99.09%38K
8.19%-4.09M
74.60%-1.64M
165.74%3.15M
89.58%-11.53M
140.83%4.17M
82.12%-4.46M
84.80%-6.45M
85.49%-4.8M
Net non-operating interest income expense
-208.50%-7.66M
-392.46%-2.48M
Non-operating interest income
-45.13%1.95M
----
----
----
----
5.53%3.55M
----
----
----
----
Non-operating interest expense
59.23%9.61M
----
----
----
----
55.95%6.03M
----
----
----
----
Other net income (expense)
-2,425.58%-10M
136.56%4.67M
-3,336.41%-13.4M
73.33%-744K
-131.68%-519K
-23.21%430K
1.97M
-393.67%-390K
-911.05%-2.79M
455.25%1.64M
Special income (charges)
---11.34M
--0
---11.34M
----
----
--0
--0
--0
----
----
-Less:Other special charges
--11.34M
--0
--11.34M
----
----
----
----
----
----
----
Other non- operating income (expenses)
211.40%1.34M
136.56%4.67M
-428.97%-2.06M
73.33%-744K
-131.68%-519K
-23.21%430K
--1.97M
-393.67%-390K
-911.05%-2.79M
455.25%1.64M
Income before tax
-48.71%-20.2M
-180.64%-2.95M
-260.87%-17.5M
74.22%-2.38M
183.39%2.64M
87.72%-13.58M
134.16%3.66M
80.61%-4.85M
78.04%-9.24M
90.36%-3.16M
Income tax
Net income
-48.71%-20.2M
-180.64%-2.95M
-260.87%-17.5M
74.22%-2.38M
183.39%2.64M
87.72%-13.58M
134.16%3.66M
80.61%-4.85M
78.04%-9.24M
90.36%-3.16M
Net income continuous Operations
-48.71%-20.2M
-180.64%-2.95M
-260.87%-17.5M
74.22%-2.38M
183.39%2.64M
87.72%-13.58M
134.16%3.66M
80.61%-4.85M
78.04%-9.24M
90.36%-3.16M
Minority interest income
Net income attributable to the parent company
-48.71%-20.2M
-180.64%-2.95M
-260.87%-17.5M
74.22%-2.38M
183.39%2.64M
87.72%-13.58M
134.16%3.66M
80.61%-4.85M
78.04%-9.24M
90.36%-3.16M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-48.71%-20.2M
-180.64%-2.95M
-260.87%-17.5M
74.22%-2.38M
183.39%2.64M
87.72%-13.58M
134.16%3.66M
80.61%-4.85M
78.04%-9.24M
90.36%-3.16M
Basic earnings per share
-33.33%-0.12
-200.00%-0.02
-233.33%-0.1
66.67%-0.02
200.00%0.02
88.75%-0.09
140.00%0.02
82.35%-0.03
82.86%-0.06
92.59%-0.02
Diluted earnings per share
-33.33%-0.12
-200.00%-0.02
-233.33%-0.1
66.67%-0.02
200.00%0.02
88.75%-0.09
140.00%0.02
82.35%-0.03
82.86%-0.06
92.59%-0.02
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 7.36%154.9M-0.47%40.59M16.47%38.21M3.26%37.2M12.21%38.9M13.57%144.29M19.13%40.78M4.38%32.81M13.42%36.02M17.07%34.67M
Operating revenue 7.36%154.9M-0.47%40.59M16.47%38.21M3.26%37.2M12.21%38.9M13.57%144.29M19.13%40.78M4.38%32.81M13.42%36.02M17.07%34.67M
Cost of revenue 6.98%41.35M8.71%11.12M25.97%11.91M-6.28%9.86M0.15%8.46M-40.64%38.65M3.47%10.23M-48.06%9.46M-47.82%10.52M-49.90%8.44M
Gross profit 7.50%113.56M-3.55%29.47M12.62%26.3M7.20%27.34M16.09%30.45M70.55%105.64M25.48%30.55M76.56%23.35M119.80%25.51M105.52%26.23M
Operating expense -0.91%116.1M11.57%29.43M9.28%30.39M-9.30%28.98M-12.03%27.29M-32.10%117.17M-23.69%26.38M-27.11%27.81M-40.84%31.95M-32.30%31.02M
Selling and administrative expenses 3.17%103.67M10.70%25.69M15.32%26.92M-5.35%26.05M-5.31%25.01M-24.69%100.48M-13.32%23.2M-19.14%23.35M-32.55%27.52M-28.58%26.42M
-Selling and marketing expense 4.20%49.06M10.64%12.23M17.95%12.94M-14.98%11.58M7.59%12.31M-30.39%47.09M-10.31%11.06M-15.31%10.97M-35.80%13.61M-45.91%11.44M
-General and administrative expense 2.26%54.61M10.76%13.45M12.99%13.98M4.07%14.47M-15.17%12.7M-18.82%53.4M-15.88%12.15M-22.25%12.37M-29.03%13.91M-5.43%14.97M
Research and development costs -25.50%12.43M17.87%3.75M-22.28%3.47M-33.80%2.93M-50.54%2.28M-57.37%16.68M-59.27%3.18M-51.91%4.47M-66.45%4.43M-47.85%4.61M
Operating profit 77.98%-2.54M-99.09%38K8.19%-4.09M74.60%-1.64M165.74%3.15M89.58%-11.53M140.83%4.17M82.12%-4.46M84.80%-6.45M85.49%-4.8M
Net non-operating interest income expense -208.50%-7.66M-392.46%-2.48M
Non-operating interest income -45.13%1.95M----------------5.53%3.55M----------------
Non-operating interest expense 59.23%9.61M----------------55.95%6.03M----------------
Other net income (expense) -2,425.58%-10M136.56%4.67M-3,336.41%-13.4M73.33%-744K-131.68%-519K-23.21%430K1.97M-393.67%-390K-911.05%-2.79M455.25%1.64M
Special income (charges) ---11.34M--0---11.34M----------0--0--0--------
-Less:Other special charges --11.34M--0--11.34M----------------------------
Other non- operating income (expenses) 211.40%1.34M136.56%4.67M-428.97%-2.06M73.33%-744K-131.68%-519K-23.21%430K--1.97M-393.67%-390K-911.05%-2.79M455.25%1.64M
Income before tax -48.71%-20.2M-180.64%-2.95M-260.87%-17.5M74.22%-2.38M183.39%2.64M87.72%-13.58M134.16%3.66M80.61%-4.85M78.04%-9.24M90.36%-3.16M
Income tax
Net income -48.71%-20.2M-180.64%-2.95M-260.87%-17.5M74.22%-2.38M183.39%2.64M87.72%-13.58M134.16%3.66M80.61%-4.85M78.04%-9.24M90.36%-3.16M
Net income continuous Operations -48.71%-20.2M-180.64%-2.95M-260.87%-17.5M74.22%-2.38M183.39%2.64M87.72%-13.58M134.16%3.66M80.61%-4.85M78.04%-9.24M90.36%-3.16M
Minority interest income
Net income attributable to the parent company -48.71%-20.2M-180.64%-2.95M-260.87%-17.5M74.22%-2.38M183.39%2.64M87.72%-13.58M134.16%3.66M80.61%-4.85M78.04%-9.24M90.36%-3.16M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -48.71%-20.2M-180.64%-2.95M-260.87%-17.5M74.22%-2.38M183.39%2.64M87.72%-13.58M134.16%3.66M80.61%-4.85M78.04%-9.24M90.36%-3.16M
Basic earnings per share -33.33%-0.12-200.00%-0.02-233.33%-0.166.67%-0.02200.00%0.0288.75%-0.09140.00%0.0282.35%-0.0382.86%-0.0692.59%-0.02
Diluted earnings per share -33.33%-0.12-200.00%-0.02-233.33%-0.166.67%-0.02200.00%0.0288.75%-0.09140.00%0.0282.35%-0.0382.86%-0.0692.59%-0.02
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -